Get started Log in

4528 — ONO PHARMACEUTICAL Share News

0.000.00%

Last trade - 00:00

HealthcareConservativeLarge CapSuper Stock

Market Cap
¥1tn
Enterprise Value
¥1tn
Revenue
¥516bn

Covid Science: Gilead's remdesivir fails to show benefit in European trial; no fetus risk seen with first trimester vaccination
04/04/2022 19:37
Table: Ono Pharm -9-MTH group results (IFRS)
07/02/2022 17:37
Table: Ono Pharm -9-MTH group results (IFRS)
31/01/2022 03:00
Table: Ono Pharm -6-MTH group results (IFRS)
01/11/2021 03:00
Table: Ono Pharm -Q1 group results (IFRS)
30/07/2021 04:00
Table: Ono Pharm -2021/22 group forecast
13/05/2021 24:40
Table: Ono Pharm -2020/21 group results (IFRS)
11/05/2021 04:00
Table: Ono Pharm -2020/21 div forecast
28/04/2021 04:00
Table: Ono Pharm -9-MTH group results (IFRS)
01/02/2021 03:00
Forxiga approved in Japan for heart failure
30/11/2020 07:00
Table: Ono Pharm -6-MTH group results (IFRS)
29/10/2020 03:00
Refinitiv Newscasts - Australia's COVID-19 hotspot partially eases lockdown
19/10/2020 09:09
Brief: SK Biopharmaceuticals says Co And Ono Pharmaceutical Enter Licensing Agreement For Cenobamate In Japan
13/10/2020 14:18
Brief: AGC Biologics Enters Into Partnership With Ono Pharmaceuticals
13/08/2020 14:12
Table: Ono Pharm -Q1 group results (IFRS)
31/07/2020 04:00
Table: Ono Pharm -2019/20 group results (IFRS)
12/05/2020 04:00
Table: Ono Pharm -9-MTH group results (IFRS)
31/01/2020 03:00
Table: Ono Pharm -6-MTH group results (IFRS)
31/10/2019 03:00
Brief: Bristol-Myers' Opdivo Shows Significant Overall Survival Benefit Vs. Chemotherapy In Esophageal Cancer Patients
30/09/2019 15:42
Table: Ono Pharm -Q1 group results (IFRS)
01/08/2019 04:00